Zhengye Biotechnology Holding (ZYBT) Short term Debt (2023 - 2025)

Zhengye Biotechnology Holding has reported Short term Debt over the past 3 years, most recently at $9.2 million for Q4 2025.

  • Quarterly Short term Debt fell 11.43% to $9.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.2 million through Dec 2025, down 11.43% year-over-year, with the annual reading at $100000.0 for FY2025, 99.02% down from the prior year.
  • Short term Debt was $9.2 million for Q4 2025 at Zhengye Biotechnology Holding, up from $28000.0 in the prior quarter.
  • Over five years, Short term Debt peaked at $11.1 million in Q4 2023 and troughed at $28000.0 in Q2 2025.
  • The 3-year median for Short term Debt is $9.8 million (2024), against an average of $7.7 million.
  • Year-over-year, Short term Debt decreased 6.56% in 2024 and then fell 11.43% in 2025.
  • A 3-year view of Short term Debt shows it stood at $11.1 million in 2023, then fell by 6.56% to $10.4 million in 2024, then decreased by 11.43% to $9.2 million in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Short term Debt are $9.2 million (Q4 2025), $28000.0 (Q2 2025), and $10.4 million (Q4 2024).